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The assembly of neuronal networks during de-
velopment requires tightly controlled cell-cell
interactions. Multiple cell surface receptors
that control axon guidance and synapse matu-
ration have been identified. However, the sig-
naling mechanisms downstream of these re-
ceptors have remained unclear. Receptor
signals might be transmitted through dedicated
signaling lines defined by specific effector pro-
teins. Alternatively, a single cell surface recep-
tor might couple to multiple effectors with over-
lapping functions. We identified the neuronal
RacGAP a2-chimaerin as an effector for the
receptor tyrosine kinase EphA4. a2-Chimaerin
interacts with activated EphA4 and is required
for ephrin-induced growth cone collapse in
cortical neurons. a2-Chimaerin mutant mice
exhibit a rabbit-like hopping gait with synchro-
nous hindlimb movements that phenocopies
mice lacking EphA4 kinase activity. Anatomical
and functional analyses of corticospinal and
spinal interneuron projections reveal that loss
of a2-chimaerin results in impairment of
EphA4 signaling in vivo. These findings identify
a2-chimaerin as an indispensable effector for
EphA4 in cortical and spinal motor circuits.
INTRODUCTION
Cell surface recognition and signaling receptors enable
developing neurons to detect cues in their environment
and respond to these cues by alterations in migration,
growth, and cellular differentiation. Work over the past
20 years has led to the identification of an array of surface
receptors and ligands that underlie specific axonal guid-
ance decisions, but the downstream signaling mecha-
nisms are only poorly understood (Dickson, 2002; Raper,
2000; Tessier-Lavigne and Goodman, 1996; Yu and Barg-
mann, 2001). Several activated receptors couple to Rho
GTPase-activating proteins (GAPs) and guanosine nucle-
otide exchange factors (GEFs) that drive local inactivation768 Neuron 55, 768–778, September 6, 2007 ª2007 Elsevier Inor activation of the Rho family of GTPases, respectively,
and thereby ultimately control cytoskeletal andmembrane
dynamics in growth cones (Luo, 2002; Shamah et al.,
2001; Wong et al., 2001; Yang and Bashaw, 2006). The
logic by which GAP and GEF effector proteins transduce
surface receptor signals has remained unclear. Analysis
of the human genome sequence predicts 69 GEFs and
up to 70 GAPs for Rho family GTPases; however, the bio-
logical relevance of this molecular diversity is not well un-
derstood (Peck et al., 2002; Schiller, 2006; Tcherkezian
and Lamarche-Vane, 2007). Biochemical studies suggest
that a single surface receptor can interact with multiple
GAPs and GEFs and that a single GAP or GEF can interact
with multiple different surface receptors. This poses the
question whether there are dedicated Rho family GTPase
regulators that are absolutely required for one class of re-
ceptors in vivo or whether receptor signals are transduced
through multiple GAPs and GEFs that act through partially
redundant pathways and are associated with many differ-
ent surface receptors.
One particularly well-studied example of a neuronal
surface receptor is the EphA4-receptor tyrosine kinase
(Pasquale, 2005). Genetic studies in mice have implicated
EphA4 in controlling multiple axonal guidance steps, most
prominently in the locomotor circuits (Kiehn, 2006). Mice
lacking EphA4 exhibit a pronounced locomotor defect
characterized by synchronous movement of their hin-
dlimbs, which results in a rabbit-like hopping gait (Dottori
et al., 1998; Kullander et al., 2003). This behavioral pheno-
type is thought to result from aberrant midline crossing of
corticospinal tract (CST) and spinal interneuron axons
and inappropriate innervation of contralateral spinal cord
hemisegments (Dottori et al., 1998; Kullander et al.,
2001b; Yokoyama et al., 2001).
In a search for mediators of Eph-receptor forward sig-
naling, multiple Rho family GAPs and GEFs have been iso-
lated, including the EphA4 effectors ephexin-1, Vsm, and
Vav-2/-3 (Cowan et al., 2005; Irie and Yamaguchi, 2002;
Ogita et al., 2003; Penzes et al., 2003; Shamah et al.,
2001; Tanaka et al., 2004). How these multiple EphA4 ef-
fectors cooperate in vivo has remained unclear. While
knockout studies for ephexin-1 and Vav-2/-3 support im-
portant functions in axonal guidance, neither one of these
knockout models reproduces the EphA4 mutant pheno-
type (Cowan et al., 2005; Sahin et al., 2005). This could
be explained if EphA4 downstream signaling is mediatedc.
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a2-Chimaerin Is an EphA4 Signaling EffectorFigure 1. a2-Chimaerin Interacts with
Activated Eph Receptors
(A) Schematic diagram of a1- and a2-
chimaerin isoform domain structure. Both iso-
forms share identical diacylglycerol-binding
C1 and GTPase-activating protein (GAP) do-
mains; a2-chimaerin contains an additional
unique N-terminal Src-homology-2 (SH2).
(B) Pull-down assays from cortical lysates with
GST control beads (GST), or GST-SH2
beads carrying the purified recombinant a2-
chimaerin SH2 domain (SH2). Input lysates
(input) and bound proteins (GST or SH2) were
probed in western blots for EphA4 and TrkA.
(C) EphA4, EphB1, or TrkA were overex-
pressed in HEK293T cells and incubated with
GST control beads or GST-SH2 beads. Blots
show an aliquot of the total cell lysate (input)
or proteins bound to GST beads or GST-SH2
beads probed with anti-EphA4 (A4), anti-
EphB1 (B1), anti-TrkA, or anti-phosphotyrosine
antibodies (p-Tyr).
(D) GST pull-down with GST control beads or GST-SH2 beads from HEK293T cell lysates expressing full-length wild-type EphA4 (A4), EphA4-V635M
(KD), EphA4-Y596E/Y602E (EE), or EphA4-Y596E/Y602E/V635M (EE/KD). Bound proteins were probed with anti-EphA4 antibodies, and an aliquot of
the cell lysate was probed with anti-EphA4 and anti-phosphotyrosine antibodies (p-Tyr).
(E) HEK293T cells overexpressing full-length HA-tagged a2-chimaerin or a1-chimaerin were incubated with beads carrying purified recombinant
maltose-binding protein (MBP), MBP fused to the intracellular domain of EphA4 (A4), MBP fused to the intracellular domain of EphA4 treated with
l-phosphatase (A4-l), MBP fused to the intracellular domain of EphA4-Y596E/Y602E, or MBP fused to a kinase-dead mutant (V635M) of the intra-
cellular domain of EphA4 (A4-KD). Bound proteins were detected with anti-HA antibodies.
(F) a2-Chimaerin was immunoprecipitated from lysates of control HEK293 cells or cells expressing a2-chimaerin, a2-chimaerin and EphA4, or a2-
chimaerin and kinase-dead EphA4 (A4-KD). Immunoprecipitates were probed with antibodies to phosphotyrosine antibodies (p-Tyr) or a2-chimaerin
(a2). Expression of EphA4 in cell lysates was confirmed with anti-EphA4 antibodies (EphA4).through a complex signaling network composed of multi-
ple effectors with redundant functions. Alternatively,
EphA4 signaling in the locomotor circuits may depend
on highly dedicated effector proteins that have not yet
been identified.
One new family of candidate effector proteins for axonal
guidance is the chimaerins, which we recovered in a mi-
croarray screen for genes involved in axonal growth and
synapse formation (Diaz et al., 2002). Two a-chimaerin
isoforms (a1 and a2) expressed from a single genomic lo-
cus under the control of two promoters were originally
identified by Lim and colleagues (Dong et al., 1995; Hall
et al., 1990, 1993). Both isoforms share identical diacylgly-
cerol-binding (C1) and RacGAP domains, but a2-
chimaerin contains an additional Src-homology-2 (SH2)
domain (Figure 1A) (Hall et al., 1990, 1993). In a crystal
structure of the highly homologous b2-chimaerin, this
SH2 domain covers the C1 and GAP domains, suggesting
that opening of this closed conformation might be re-
quired for access to binding partners (Canagarajah
et al., 2004). The GAP domain of a2-chimaerin downregu-
lates Rac activity in vitro and in transfected cells (Ahmed
et al., 1990; Hall et al., 2001). Furthermore, overexpression
and knockdown studies suggest that a-chimaerins inacti-
vate Rac and that the a1-chimaerin isoform contributes to
dendritic retraction events in cultured neurons (Buttery
et al., 2006; Leskow et al., 2006; Van de Ven et al.,
2005). In this study, we searched for novel a2-chimaerinNeinteraction partners and identified activated Eph recep-
tors. We characterized the behavioral, anatomical, and
functional abnormalities in the locomotor circuits of
a2-chimaerin-deficient mice and discovered that they
closely resemble defects of mice lacking EphA4 kinase-
dependent functions. These findings suggest that ablation
of a single cytoplasmic effector protein results in a severe
but rather selective loss of EphA4-receptor function.
RESULTS
a2-Chimaerin Is an Eph Effector
We hypothesized that a2-chimaerin might interact via its
SH2 domain with tyrosine kinase receptors. To identify
such receptors, we performed affinity chromatography
of solubilized membrane proteins on an immobilized re-
combinant protein of the a2-chimaerin SH2 domain fused
to gluthathione S-transferase (GST). Anti-phosphotyro-
sine antibodies revealed several candidate binding pro-
teins. Based on its size and reactivity with anti-EphA4 an-
tibodies, one of these proteins was identified as EphA4
(Figure 1B). To examine the selectivity of this biochemical
interaction, we performed pull-down assays with lysates
from HEK293T cells overexpressing full-length EphA4,
EphB1, EphB2, TrkA, neurexin-1b, or SHPS1. In this as-
say, all of the tested Eph receptors were efficiently recov-
ered on GST-SH2 beads, but not on beads containing
a GST control protein (Figure 1C and data not shown).uron 55, 768–778, September 6, 2007 ª2007 Elsevier Inc. 769
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rosine kinase receptor, or the transmembrane adhesion
molecules neurexin-1b and SHPS1 (Figure 1C and data
not shown).
We next examined whether a2-chimaerin preferentially
interacts with activated, tyrosine-phosphorylated EphA4
receptors. In pull-down assays with the recombinant a2-
chimaerin SH2 domain as bait, no full-length kinase-
dead receptors were recovered (KD, V635M; Figure 1D).
In the same assay, an EphA4 mutant that maintains ki-
nase activity but has the two juxtamembrane tyrosine-
phosphorylation sites mutated to glutamate (EE; Y596E/
Y602E) (Binns et al., 2000; Holland et al., 1997; Zisch
et al., 2000) showed reduced interaction with the a2-
chimaerin SH2 domain. Finally, binding of this double-
glutamate mutant was not altered when combined with
the kinase-dead mutation (EE/KD) (Figure 1D). These in-
teractions suggest that the juxtamembrane tyrosines
play an important role in binding the a2-chimaerin SH2
domain to activated EphA4. Morevover, full-length a2-
chimaerin bound EphA4 in a kinase-activity-dependent
manner. Full-length a2-chimaerin expressed in HEK293T
cells bound efficiently to beads containing the recombi-
nant intracellular domain of the EphA4 receptor (A4) fused
to maltose-binding protein (MBP) but not to an MBP con-
trol protein (Figure 1E). Bindingwas severely reduced after
dephosphorylation of EphA4 with l-phosphatase (A4-l)
and was not detectable for EphA4 kinase-dead receptors
(A4-KD; Figure 1E). The double-glutamate mutant showed
reduced binding as compared to the wild-type EphA4. In-
terestingly, the SH2 domain of a2-chimaerin was not ab-
solutely required for interaction with recombinant EphA4.
a1-chimaerin, which lacks the SH2 domain, still interacted
with EphA4, though this interaction was not dependent on
EphA4 kinase activity. In combination, these data suggest
that a2-chimaerin contains at least two binding sites for
EphA4, one in the SH2 domain and one in the remainder
of the protein. The second binding site appears to be ac-
cessible only once the SH2 domain engages in binding to
phosphotyrosine residues in activated EphA4. Our at-
tempts to coimmunoprecipitate a2-chimaerin and EphA4
either from brain lysates or from transfected HEK293 cells
failed, suggesting that binding might be transient or show
a high off-rate. However, in cotransfected HEK293 cells,
we did observe EphA4-dependent tyrosine phosphory-
lation of a2-chimaerin, providing further evidence for
functional coupling between the two proteins (Figure 1F).
In summary, these biochemical studies identify a2-
chimaerin as a signaling effector for activated Eph
receptors that might be required for transduction of Eph-
receptor signaling.
a2-Chimaerin Mutant Mice Exhibit
Locomotor Defects
To examine the relevance of a2-chimaerin for Eph-
receptor signaling, we obtained mice with a gene-trap
insertion in the a-chimaerin gene. The trap insertion is lo-
cated upstream of the putative a1-chimaerin promoter770 Neuron 55, 768–778, September 6, 2007 ª2007 Elsevier Inc(Dong et al., 1995) and selectively suppresses a2-
chimaerin full-lengthmRNA and protein levels, without de-
tectable effect on the a1-chimaerin isoform (Figures 2A
and 2B). Heterozygous gene-trap mice did not show any
overt anatomical or behavioral phenotype. Therefore, we
used the lacZ reporter within the gene-trap cassette in
a2-chimaerin heterozygous mice to characterize the pat-
tern of a2-chimaerin expression (Figures 2A and 2C).
This analysis revealed widespread neuronal expression
consistent with previous in situ hybridization studies
(Hall et al., 1993). In postnatal day 5 cortex, a2-chimaerin
expression was detected in multiple layers, including
CTIP2-positive layer V neurons, which are the source of
corticospinal tract axons (Arlotta et al., 2005) (Figure 2C).
High expression was also observed in the retinal ganglion
cells and dorsal root ganglia (data not shown). In the spinal
cord, the lacZ reporter was detected in NeuN-positive in-
terneuron populations, including cells in the ventromedial
zone as well as presumptive motor neurons (Figure 2C).
Homozygous a2-chimaerin mutant mice are born at
Mendelian frequencies and are viable and fertile. Overall
brain architecture including the anterior commissure in
a2-chimaerin mutant mice did not show any apparent
defects (Figure 3A and data not shown). However, the ho-
mozygous mutant mice exhibit a pronounced locomotor
deficit during walking. While wild-type mice move their
hindlimbs in alternation, a2-chimaerin mutants show syn-
chronous hindlimb movement observed as a rabbit-like
hopping-gait (Figure 3B and Movies S1 and S2). Impor-
tantly, this behavioral defect phenocopies locomotor ab-
normalities observed in EphA4 mutant mice (Dottori
et al., 1998; Kullander et al., 2001a), suggesting that loss
of a2-chimaerin may impair EphA4 function.
a2-Chimaerin Is Required for Ephrin-Induced
Growth Cone Collapse
Repulsive EphA4-receptor signaling responses can be vi-
sualized in vitro as ephrin ligand-induced growth cone col-
lapse. To test whether a2-chimaerin-deficient axons had
lost their ability to respond to ephrins, we cultured cortical
explants from the presumptive motor cortex area, which
expresses high levels of EphA4 and a2-chimaerin. As ob-
served by time-lapse imaging, basal growth rates of axons
extending from wild-type and a2-chimaerin mutant ex-
plants were not significantly different over the initial
15 min of imaging (p > 0.05, t test; Figure 4C). Application
of recombinant ephrinA1-Fc fusion protein, a high-affinity
ligand specific for A-class Eph receptors, induced robust
growth cone collapse in wild-type axons within 30 min of
application (Figure 4A and Movie S3). In contrast, axons
from a2-chimaerin mutant explants were largely resistant
to ephrinA1-induced collapse (Figures 4A and 4B and
Movie S4; p = 0.004, t test). Additional measurements of
growth rates 30 min after ephrinA1 application revealed
that the mutant axons continued to advance in the pres-
ence of the repulsive cue (Figure 4C). Importantly, EphA4
staining on wild-type and mutant axons were not notice-
ably different (Figure 4D), and EphA4 protein levels in.
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a2-Chimaerin Is an EphA4 Signaling EffectorFigure 2. Characterization of a2-Chi-
maerin Gene Trap Mice
(A) The genomic locus of a-chimaerin contains
two independent promoters (arrows) that drive
transcription of the a1- and a2-chimaerin iso-
forms. The gene-trap cassette containing
a lacZ reporter is inserted upstream of the pu-
tative a1-chimaerin promoter.
(B) Western blots and RT-PCR of brain and
spinal cord lysates of adult wild-type (+/+),
heterozygous (+/), and homozygous (/)
gene-trap animals. a1- and a2-chimaerin iso-
form-specific antibody blots and RT-PCR
demonstrate that gene-trap homozygous
mutants have a specific reduction of the a2-
chimaerin protein and mRNA in both brain
and spinal cord lysates, respectively.
(C) Analysis of a2-chimaerin expression using
the lacZ reporter inserted within the gene-
trap cassette. Wild-type animals (upper
panels) do not show any detectable b-galacto-
sidase activity or significant lacZ staining. In
mice heterozygous for the gene-trap insertion
(lower panel), b-galactosidase activity is de-
tected throughout the cortex of P5 animals ex-
cept for layer I (left panel). Immunostaining with
anti-LacZ antibodies (punctate red staining) of
P5 cortex reveals overlap with the cortical layer
V specific marker CTIP2-positive cells (green)
and widespread neuronal nuclei identified by
immunoreactivity for NeuN (blue). In the lumbar
spinal cord, expressionwas observed through-
out the cord, including motor neurons (identi-
fied by their large cell bodies located in the
ventral part of the spinal cord), and in neurons
in the ventral area shown at higher magnifica-
tion on the right. Scale bar is 100 mm.lysates of the cortical explants from wild-type and mutant
mice were unchanged. Moreover, explants showed signif-
icant levels of a1-chimaerin expression, regardless of the
genotype (Figure 4E). This suggests that the a2-chimaerin
isoform is essential for the transduction of repulsive
ephrin-induced signaling in motor cortex axons in vitro.
a2-Chimaerin Mutant Mice Show Aberrant Midline
Crossing of Spinal Interneuron Projections
In the lumbar spinal cord, repulsive EphA4 signaling pre-
vents inappropriate midline crossing of spinal interneuron
axons, and the locomotor abnormalities in EphA4 mutant
mice are attributed at least in part to aberrant innervation
of the contralateral central pattern generator (CPG) (Dot-
tori et al., 1998; Kullander et al., 2001a, 2003; Yokoyama
et al., 2001). Because a2-chimaerin mutant mice exhibit
similar locomotor defects as EphA4 mutants and show re-
duced Eph-receptor-mediated repulsion, we analyzed
whether loss of a2-chimaerin causes defects in spinal in-
terneuron pathfinding. We performed unilateral injections
of rhodamine-dextran into the lumbar spinal cord segment
L4 and examined retrogradely labeled axonal projections
in transverse sections at L2 (Figure 5A). In a2-chimaerin
mutant animals, we observed an increase in the numberNeuof rhodamine-positive fibers crossing the midline as com-
pared to wild-type (Figure 5B). A significant increase in
midline crossing was further confirmed in quantitative
analysis of the label density near themidline on the contra-
lateral side (fraction of 10 3 100 mm region of interest that
is dextran positive on contralateral side: 3.7% ± 1.8% in
wild-type and 33.4% ± 5.1% in a2-chimaerin mutant spi-
nal cords, n > 12 mice per genotype, >4 consecutive sec-
tions analyzed per animal, p = 0.004, t test). In contrast,
ipsilateral labeling was similar between the two genotypes
(p = 0.42, t test). Despite the severe defect inmidline cross-
ing, other axonal projections in the spinal cord of a2-
chimaerin mutants were apparently unperturbed. We ex-
amined the central projections of proprioceptive sensory
afferents, which depend on plexinA1 signaling for axon
positioning within the dorsal spinal cord (Yoshida et al.,
2006). Immunostaining with antibodies to parvalbumin,
a marker of proprioceptive afferents (Arber et al., 2000),
revealed that parvalbumin-positive axons were similarly
excluded from the superficial dorsal horn in wild-type
and a2-chimaerin mutant spinal cords (Figure S1). There-
fore, a2-chimaerin is required for restricting midline cross-
ing of interneurons in the lumbar spinal cord but not for the
positioning of proprioceptive sensory afferents.ron 55, 768–778, September 6, 2007 ª2007 Elsevier Inc. 771
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a2-Chimaerin Is an EphA4 Signaling EffectorFigure 3. a2-Chimaerin Mutant Mice
Show Locomotor Abnormalities
(A) Horizontal brain sections from adult wild-
type and a2-chimaerin mutants visualizing the
anterior (aAC) and posterior (pAC) sections of
the anterior commissure. Scale bar is 1 mm.
(B) Images and footprints of wild-type animals
display an alternating hindlimb gait, while a2
gene-trap mutants display a synchronous rab-
bit-like hopping gait. Direction of animal move-
ment is from left to right. Blue represents the
left forelimb, red is right forelimb, green is left
hindlimb, and yellow is right hindlimb. See
Movies S1 and S2 of wild-type and mutant an-
imals, respectively. Scale bar is 1 cm.To test whether EphA4 and a2-chimaerin genetically in-
teract in restrictingmidline crossing of spinal interneurons,
we examined single and double heterozygous EphA4 and772 Neuron 55, 768–778, September 6, 2007 ª2007 Elsevier Inca2-chimaerinmutantmice.While single heterozygousmu-
tants did not show any overt phenotype, a2-chimaerin+/;
EphA4+/ double heterozygotes exhibited a partiallyFigure 4. Impaired Ephrin-Induced
Growth Cone Collapse in a2-Chimaerin
Mutant Axons
(A) Representative examples of time-lapse im-
aged growth cones from wild-type and a2
mutants before and after application of eph-
rinA1-Fc (1 mg/ml). Scale bar is 10 mm.
(B) Quantification of the percentage of growth
cones collapsing after application of recombi-
nant Fc protein or ephrinA1-Fc for explants
from wild-type and a2-chimaerin mutant
mice. The number of growth cones imaged
per condition was 34 (wild-type + Fc), 85
(wild-type + ephrinA1), 27 (mutant + Fc), 113
(mutant + ephrinA1). Error bars are SEM.
(C) Growth rate before and after addition of
EphrinA1 measured for 15 min before and
30 min after addition of ephrinA1-Fc. Growth
cone advancement is shown as positive, re-
traction as negative values. Error bars are
SEM.
(D) The expression level of EphA4 is similar at
the growth cone of axons from cultured cortical
neurons of wild-type and a2-chimaerin mutant
mice. Staining for the EphA4 receptor (red) and
phalloidin (green). Scale bar is 10 mm.
(E) Western blots of lysates of the cortical explants used in the collapse assays from P1 wild-type (+/+) and homozygous (/) gene-trap animals.
Detection with EphA4- and a1-chimaerin-specific antibodies demonstrates unchanged levels of total EphA4 and a1-chimaerin protein levels. The
same blot was stripped and reprobed with an anti-tubulin antibody as a loading control..
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a2-Chimaerin Is an EphA4 Signaling EffectorFigure 5. Spinal Interneurons Have Ab-
errant Projections that Cross the Midline
in a2-Chimaerin Mutant Mice
(A) Schematic diagram of the lumbar spinal
cord highlighting the site of unilateral rhoda-
mine-dextran application (red rectangle at L4)
and the labeling observed in the contralateral
L2 segment (blue dashed box).
(B) Retrograde labeling using rhodamine-
dextran amine to determine the contralateral
projections in wild-type mice, a2-chimaerin/
mutant mice, and a2-chimaerin+/; EphA4+/
double heterozygous mice. The boxed area is
enlarged in the lower panel. Many fibers cross
the midline below and above the central canal
(white circle) in the mutant spinal cords. Scale
bar is 100 mm.
(C) a2-chimaerin/ mutants and a2-
chimaerin+/; EphA4+/ double heterozygous
mutant mice exhibit a more shallow and wid-
ened dorsal funiculus (DF) and an expansion
of the dorsal gray matter above the central
canal as compared to wild-type animals. The
quantitation shows the ratio of height:width
measurements for the dorsal funiculus (n > 4 mice per genotype, 3 sections per animal). Compared to wild-type mice, the DF morphology was
most severely altered in a2-chimaerin/mutant mice (p < 0.01, Bonnferroni’s multiple comparisons test). No significant differences were observed
when comparing wild-type and single heterozygous mutant mice (p > 0.05), whereas a2-chimaerin+/; EphA4+/ double heterozygous mutants were
significantly different from each single heterozygous mutant as well as fromwild-type and a2-chimaerin/ homozygous mutants (p < 0.01). The cen-
tral canal is marked by a white circle; the dashed lines represent measures of height and width of the dorsal funiculus.penetrant hindlimb locomotor phenotype characterized
by perturbed hindlimb coordination and occasional syn-
chronous hindlimb movements. Rhodamine dextran trac-
ing revealed increased midline crossing of fibers as com-
pared to thewild-typemice. A genetic interaction between
EphA4 and a2-chimaerin was also observed at the level of
spinal cord morphology. The dorsal funiculus in EphA4
mutant mice is broader and more shallow than in wild-
type or heterozygous mutant mice (Dottori et al., 1998;
Kullander et al., 2001a, 2001b). This phenotype is also ob-
served in a2-chimaerin mutants, and a2-chimaerin+/;
EphA4+/ double heterozygotes show a similar though
somewhat less severe defect (Figures 5C and 5D). These
findings provide genetic evidence supporting the a2-
chimaerin-EphA4 interactions observed in our biochemi-
cal studies and strongly suggest that both proteins act in
a common signaling pathway in vivo.
Corticospinal Defects in a2-Chimaerin
Mutant Mice
We next examined CST projections in a2-chimaerin mu-
tant mice. The anterograde tracer biotin-dextran amine
was injected into one side of the motor cortex of adult
mice, and descending CST axonal projections in the spi-
nal cord were observed 10–12 days later (Figure 6A).
Wild-type animals exhibited strictly contralateral labeling
within the dorsal funiculus and predominantly contralat-
eral terminations within the spinal gray matter (Figure 6B).
In a2-chimaerin mutant mice, CST axons were also re-
stricted to the contralateral dorsal funiculus. However,
there were extensive bilateral terminations within the spi-Nenal gray matter, indicating that a2-chimaerin mutant CST
axons fail to respect the repulsive ephrin barrier along
the midline (Figures 6B and 6C; n = 5 animals/genotype,
4 sections/animal, p = 0.008, t test). Taken together, our
anatomical studies demonstrate that a2-chimaerinmutant
mice selectively phenocopy defects resulting from
impaired EphA4 forward signaling in spinal and cortical
motor circuits in vivo.
a2-Chimaerin Mutants Show Bilateral Hindlimb
Movements in Response to Cortical Stimulation
The anatomical studies reveal inappropriate midline
crossing for the axons of corticospinal motor neurons
and spinal interneurons. To directly test whether the loss
of bilateral segregation of these axonal pathways was re-
sponsible for the functional defects in a2-chimaerin mice,
we performed extracellular microstimulation within the
hindlimb representation of the motor cortex (Li and Wa-
ters, 1991) and observed hindlimb movements and mus-
cle activation. In wild-type animals, a threshold stimulus
(18.75 ± 0.75 mA, n = 4 animals) applied in motor cortex
of one cortical hemisphere resulted in exclusively contra-
lateral EMGs and hindlimb flexion (Figure 7A). Weak ipsi-
lateral hindlimb responses in wild-type animals could be
recruited only with supramaximal stimuli (66 ± 11 mA,
n = 4 animals). In contrast, unilateral stimulation of motor
cortex in a2-chimaerin mutant mice evoked exclusively bi-
lateral EMGs and hindlimb flexion at threshold intensity
(21 ± 4.02 mA, n = 4; Figures 7A and 7B). These bilateral re-
sponses in a2-chimaerin mutant mice might result from
bilateral CST projections that trigger local spinal motoruron 55, 768–778, September 6, 2007 ª2007 Elsevier Inc. 773
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a2-Chimaerin Is an EphA4 Signaling EffectorFigure 6. Aberrant Corticospinal Tracts in a2-Chimaerin Mutants
(A) Schematic diagram of injection site and anterograde labeling of corticospinal tract axons.
(B) Darkfield micrographs of anterogradely labeled CST projections in the spinal cord of wild-type and a2-chimaerin mutant animals shown in hor-
izontal (left) and transverse (right) sections of the cervical spinal cord. The column on the right shows an enlargement of the midline area below the DF
in the transverse section. Scale bar is 100 mm; error bars are SEM.
(C) Quantification of axonal labeling was performed by placing a 100 3 100 mm region of interest in the ipsilateral or contralateral gray matter and
measuring tracer-positive pixels to estimate axon density on each spinal hemisegment (n = 5 animals per genotype, 4 sections per animal).circuits on both sides of the spinal cord. Alternatively, bi-
lateral stimulus-evoked responses might be due to con-
tralateral CST projections that activate interneurons of spi-
nal motor circuits with aberrant bilateral connections to
motor neurons. In either scenario, our data suggest that
the wiring defects in spinal motor circuits are responsible
for hindlimb synchrony in the a2-chimaerin mutant mice.
DISCUSSION
Our findings provide several important insights into the
mechanisms of Eph-receptor signaling. We demonstrate
that a2-chimaerin is a downstream effector for EphA4.
Loss of a2-chimaerin results in a close phenocopy of the
anatomical and locomotor defects in EphA4 knockin
mice expressing a kinase-dead receptor. Biochemical
and genetic evidence supports an interaction between ac-
tivated EphA4 and a2-chimaerin. Jointly, these findings
suggest that a2-chimaerin is a dedicated signaling effec-
tor that is essential for EphA4-receptor forward signaling
in cortical and spinal motor circuits.
Several lines of evidence support theconclusion that ab-
normalities in the a2-chimaerin mutant mice are due to an
impairment of downstream signaling and not simply a lack
of EphA4-receptor expression. Our biochemical studies
suggest an interaction with activated EphA4 and EphA4-774 Neuron 55, 768–778, September 6, 2007 ª2007 Elsevier Idependent tyrosine phosphorylation of a2-chimaerin.
Moreover, EphA4 protein levels in tissue lysates and in ax-
onal growth cones are unaltered in the a2-chimaerin mu-
tant mice, and, most importantly, formation of the anterior
commissure, which depends on EphA4 reverse signaling,
is normal in a2-chimaerin mutants. Therefore, the pheno-
copy of the EphA4-receptor mutant in the corticospinal
tract and spinal interneuron projections of a2-chimaerin
mutant mice is due to the loss of an indispensable down-
stream signaling function of the a2-chimaerin protein.
The biochemical interactions and regulation of Rac
activity by a2-chimaerin are likely to be complex. The
a2-chimaerin isoform appears to exist in a closed con-
formation. Our data suggest that opening of this confor-
mation can be achieved by SH2-domain-dependent bind-
ing to tyrosine-phosphorylated EphA4, which then
exposes an additional a2-chimaerin-EphA4 interaction
site. This opening might also be required tomake the Rac-
GAP domain available for Rac binding and inactivation,
as has been suggested for b2-chimaerin based on struc-
tural studies (Canagarajah et al., 2004). Previous work
suggests that chimaerin function can be further regulated
by Src- and Cdk5-mediated phosphorylation events, as
well as by diacylglycerol generated from PLCb- or
PLCg-coupled receptors (Brown et al., 2004; Buttery
et al., 2006; Caloca et al., 1999; Canagarajah et al.,Figure 7. Cortical Stimulation Evokes
Bilateral Hindlimb Movement in a2-Chi-
maerin Mutant Mice
(A) Representative EMG data from contralat-
eral and ipsilateral hindlimb muscles in re-
sponse to threshold cortical stimulation
(20 mA) in wild-type and a2-chimaerin mutant
animals. Scale bar is 5 mV.
(B) Average stimulus intensity measurements
for eliciting contralateral or ipsilateral hindlimb
flexion in wild-type and a2-chimaerin mutant
animals. Error bars are SEM.nc.
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a2-Chimaerin Is an EphA4 Signaling Effector2004; Kai et al., 2007; Qi et al., 2004; Wang et al., 2006).
How these different signaling pathways intersect down-
stream of EphA4 remains to be shown.
Notably, a recent proteomic analysis of an EphB2-
overexpressing cell line identified b2-chimaerin in phos-
photyrosine-containing protein complexes after EphB2
stimulation (Zhang et al., 2006). Therefore, b2-chimaerin
may also be recruited by Eph-receptor activation. How-
ever, our data indicate that neither a1- nor b2-chimaerin
isoforms can compensate for the loss of a2-chimaerin
in vivo. The severe impairment of EphA4 forward signaling
in a2-chimaerin mutant mice suggests that, with respect
to other effectors, there is no redundancy in the signaling
pathways downstream of EphA4. How can this be ex-
plained considering that EphA4 interacts with multiple
RhoGTPase GAPs and GEFs? Ablation of ephexin-1 or
Vav-2/Vav-3, which couple to activated EphA4 receptors,
does not phenocopy the locomotor defects observed in
EphA4 and a2-chimaerin mutant mice. Rather, these mu-
tants show defects in retinal ganglion cell axon guidance
(Cowan et al., 2005; Sahin et al., 2005). Therefore, dedi-
cated Eph-receptor effectors might act in a cell-type-
specific manner. The significant number of proteins with
predicted GAP or GEF domains encoded in mammalian
genomes would make such a scenario possible. Alterna-
tively, multiple RhoGTPase regulators might act sequen-
tially within the same cell type. Studies in retinal axons
reported ephrin-induced downregulation of Rac activity
withinminutes followed by an increase of active Rac levels
over the next 30 min (Jurney et al., 2002). Therefore, a2-
chimaerin-mediated Rac inactivation might represent an
early step in EphA4-mediated responses followed by an
increase in active Rac through the RacGEF activity of
Vav-2 and/or Vav-3, which might result in Eph-receptor
endocytosis and termination of signaling (Cowan et al.,
2005). In this latter scenario, only the first a2-chimaerin-
dependent step would exclusively rely on a single effector
protein; whereas, the subsequent steps might be con-
trolled through multiple overlapping pathways. Regard-
less of the exact mechanism, our data demonstrate that
a2-chimaerin is essential for EphA4 signaling in spinal
locomotor circuits.
The second important observation in our study is the se-
lectivity of the a2-chimaerin phenotype. Previous studies
highlighted axon guidance defects in several central regu-
lators of the cytoskeleton, including the RhoGTPases, PI3-
kinase, Abelson kinase, and Ena/VASP family proteins,
which are common signalingmediators for multiple neuro-
nal surface receptors (Bashaw et al., 2000; Chang et al.,
2006; Lebrand et al., 2004; Ng and Luo, 2004; Wills
et al., 1999). The defects in a2-chimaerin mutant mice
appear to be rather selective for EphA4-dependent
pathways. Previous work suggested a function for a2-
chimaerin in semaphorin/plexin-induced growth respon-
ses in cultured DRG neurons (Brown et al., 2004). We
found that plexinA1-dependent central projections of
proprioceptive afferents were not perturbed in a2-
chimaerin mutants. Therefore, a2-chimaerin is either notNeinvolved in plexin signaling in vivo or other Rho regulators,
including other chimaerin isoforms, act redundantly with
a2-chimaerin in this pathway. Our biochemical studies
also suggest an interaction of a2-chimaerin with EphB re-
ceptors. This warrants future studies to test whether a2-
chimaerin is a dedicated effector for EphA4 or whether it
also transduces EphB receptor signaling events in vivo.
EXPERIMENTAL PROCEDURES
cDNAs and Recombinant Proteins
Full-length and mutant EphA4 cDNAs were generously provided by
Dr. Greenberg. The following recombinant proteins were purified
from E. coli and coupled to glutathione sepharose or NHS-activated
sepharose beads: glutathione S-transferase (GST); GST-SH2, contain-
ing amino acids 1–182 of murine a2-chimaerin; maltose-binding pro-
tein (MBP); MBP-A4, containing residues 572–978 (the intracellular do-
main) of murine EphA4; MBP-A4/KD containing the intracellular
domain with a V635M mutation; and MBP-A4/EE containing the intra-
cellular domain with Y596E and Y602E mutations.
Biochemical Assays
Mouse brains fromP14 animals were homogenized and separated into
cytosol, membrane, and nuclear fractions. Themembrane fractionwas
solubilized in 50 mM HEPES (pH 7.5), 1% triton X-100, 0.5% sodium-
deoxycholate, 10% glycerol, 100 mM NaCl, 1.5 mM MgCl2, 1 mM
EGTA, 10 mMNaF, 1 mM Na3VO4, and the solubilized membrane pro-
teins were passed over a column with purified recombinant SH2 do-
main of a2-chimaerin fused to GST. Proteins were eluted with increas-
ing sodium chloride concentrations (50 mM to 2 M NaCl), and eluted
proteins were analyzed by silver staining and western blotting. For
the pull-down assays, all cDNA expression vectors used for expres-
sion of proteins contained the CMV immediate-early promoter and epi-
tope tags for detection. HEK293T cells were transiently transfected us-
ing Fugene (Roche). Sixteen hours after transfection, cells were lysed
in 50 mM HEPES (pH 7.5), 0.5% triton X-100, 10% glycerol, 1.5 mM
MgCl2, 1 mM EGTA, 100 mM NaF, and 1 mM Na3VO4. Pull-downs
with GST-SH2 beads were performed with 150 ml cell or tissue lysate
diluted in 450 ml 20 mM HEPES (pH 7.5), 50 mM NaCl, 10% glycerol,
1 mM EGTA, 1.5 mM MgCl2, 1 mM NaF, 1 mM Na3VO4, for 3 hr at
4C. MBP/MBP-A4/MBP-KD beads were preincubated in ‘‘Kinase
Buffer’’ (20 mM HEPES [pH 7.5], 50 mM NaCl, 6 mM MgCl2, 4 mM
MnCl2, 0.1 mM Na3VO4) or l-phosphatase buffer (NEB) with 100 mM
ATP or l-phosphatase. Pull-downs were performed with 150 ml cell
lysate diluted in 450 ml ‘‘Kinase-Buffer’’ for 3 hr at 4C. After all pull-
downs, the beads were washed three times with 20 mM HEPES,
120 mM NaCl, 0.2% triton X-100, 10% glycerol, 1 mM EGTA, 1.5 mM
MgCl2, 1mMNaF, 1mMNa3VO4. All pull-downs were performed in the
presence of complete protease inhibitor EDTA free (Roche), one tablet
per 10 ml. Proteins were resolved on SDS-PAGE gels, transferred to
nitrocellulose, and immunoblotted with the indicated antibodies.
Antibodies
Rat monoclonal anti-HA (Roche, clone 3F10), mouse monoclonal anti-
EphA4 receptor (Zymed, clone 4C8H5), rabbit anti-EphA4 (generously
provided by Dr. Pasquale), rabbit anti-TrkA (Santa Cruz), mouse anti
phospho-tyrosine (Santa Cruz, PY99), anti a1 and a2-chimaerin (But-
tery et al., 2006), rat anti-CTIP2 (Abcam), goat anti-b-galactosidase
(Biogenesis), mouse anti-NeuN (Chemicon), goat anti-parvalbumin
(Swant). Secondary antibodies were from Jackson Immuno Research;
for IP-western analysis, secondary antibodies specific to the antibody
light chains were used to minimize detection of IgG used for immuno-
precipitation.uron 55, 768–778, September 6, 2007 ª2007 Elsevier Inc. 775
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Mice containing a gene-trap insertion in the a-chimaerin genewere ob-
tained from Lexicon Genetics. EphA4 mutant mice were previously
generated and generously provided by Dr. Patrick Charnay (Helm-
bacher et al., 2000). Spinal cords of postnatal day 5 mice were dis-
sected by ventral laminectomy in cold L15 media (Mediatech). Spinal
neuronal projections to the contralateral side of the cord were retro-
gradely labeled by applying crystals of rhodamine dextran (3000 MW,
Molecular Probes) to a unilateral cut at the L3/L4 transition. The iso-
lated spinal cords were incubated in oxygenated retrograde transport
solution (in mM: 137 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 0.2% w/v glucose,
1 NaH2PO4, 24 NaHCO3 [pH 7.4]) for 8–12 hr before immersion fixation
and sectioning. Labeled spinal cords were fixed in 4% PFA in 13 PBS
for 2 hr, and 50 mm serial vibratome sections were collected and
mounted in Fluoromount-G (Southern Biotech). Axon labeling in at
least four consecutive sections at the L2 level were analyzed for quan-
tification of retrograde labeling.
Corticospinal Tract Tracing
Adult animals were anesthetized with a ketamine/xylazine mix (100/10
mg/kg body weight; i.p.), and the motor cortex was pressure injected
with the anterograde tracer biotin dextran amine (10% BDA in 0.1 M
PBS; Molecular Probes, 400 nl into four sites covering the forelimb
to hindlimb representation in motor cortex). After 10–11 days, the an-
imals received an overdose of ketamine/xylazine and were transcar-
dially perfused with 13 PBS, followed by 4% PFA in 13 PBS. Spinal
cords were isolated and postfixed for 2 hr at room temperature fol-
lowed by overnight immersion in 30% sucrose. Frozenmicrotome sec-
tions of traced brain and spinal cord (50 mm) were collected and incu-
bated overnight with an avidin-biotin-peroxidase complex (Vectastain
ABC Elite Kit, 1:100 in PBS) at room temperature. Sections were re-
acted with diaminobenzidine (DAB), washed, mounted, coverslipped
on glass slides, and examined under darkfield optics using a Zeiss
Axioimager microscope.
Corticospinal Stimulation and EMG Recording
Cortical stimulation was performed by stereotaxic insertion of paral-
een-insulated tungsten microelectrodes (Microprobe Inc.) into hin-
dlimb motor cortex. Using a constant current stimulator, trains of bi-
phasic initially cathodal stimuli (45 ms, 333 Hz, 0.2 ms pulse duration,
trains every 2 s) of increasing intensity were applied until a contralateral
hindlimb movement was evoked, whereupon we noted the current
(threshold) and the presence or absence of an ipsilateral hindlimb re-
sponse. Multiple stimuli at threshold intensities were applied to ensure
reliable threshold measurements. In wild-type, stimuli at multiples of
threshold (up to 5 times) were applied to recruit and ipsilateral hindlimb
response in addition to a contralateral hindlimb response.We recorded
EMG activity using Ni-chromewires inserted percutaneously into mus-
cle. The hindlimbswere shaved to facilitatemuscle identification and to
ensure accurate electrode placement. We used conventional amplifi-
cation and filtration. For this study, we inspected the recorded EMG
during the experiment for concordance between the kinematic effect
of stimulation and the pattern of EMG activation.
Growth Cone Collapse Assay
Developingmotor cortices fromP1mouse pupswere dissected in cold
L15 media (Cellgro). Cortical explants were plated in medium (Neuro-
basal, 13 B27 supplement, 1X penicillin/streptomycin/glutamine mix,
1.2 mMMgCl2, 35 mMglucose) onMatTek glass bottom plates coated
with 100 mg/ml poly D-lysine and 20 mg/ml Laminin (Invitrogen) and
placed in a 37C/5% CO2 incubator. After 2 days in culture, explant
plates were transferred to a 37C/5% CO2 environment microscope
for time-lapse image analysis. Individual axonal growth cones from
the explants were imaged for a total of 45 min with a 633 1.4 NA Zeiss
objective. Growth cones were imaged for 15 min before treatment to
determine basal growth rates. After 15 min, 250 ml (1 mg/ml of control
Fc protein or ephrinA1-Fc fusion protein) was bath applied to explants,776 Neuron 55, 768–778, September 6, 2007 ª2007 Elsevier Inand time-lapse imaging proceeded for an additional 30 min. Each
growth cone was imaged at 30 s intervals before and after treatment.
Growth cone collapse and distance traveled were scored blind toward
genotype using Metamorph image analysis software.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/55/5/768/DC1/.
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